Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 70 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
18-70 years old (inclusive)
Admission to NSICU with a diagnosis of SAH or ICH
Patients who are admitted >48 hours after SAH or ICH
Readmission or second SAH
Readmission or second ICH
Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage